Our Editor-in-Chief Professor Rafael Franco well-promoted and introduced ENT journal to participants at the "International Congress on Neurodegenerative Diseases" held in Spain on September 19-22, 2023.
The Congress has been organized, since 2013, by Queen Sofia Foundation, together with CIEN Foundation and CIBERNED and, this year, for the first time, by the Spanish Society of Neurology. This scientific Congress aims to bring society closer to the advances of research in the fight against Alzheimer's and other neurodegenerative diseases and, above all, to raise the evident need to advance in the search for global solutions and responses due to their social consequences. It offers a forum to discuss a range of areas of interest related to basic, clinical, and translational aspects of the research on neurodegenerative diseases, providing researchers from all over the world with opportunities to discuss and share experiences and entertain topics that stretch into the future.
We believe that through Prof. Franco's promotion at the congress, more neurological researchers will know and pay attention to ENT, an open-access journal with no APC before July 31, 2026. In the future, we will continue to promote more conference opportunities to increase the exposure of the journal. So we also welcome more experts like Prof. Franco to join us to promote the journal, and we will provide every support.
COPE Membership of Exploration of Neuroprotective Therapy Approved
ENT’s Editorial Board Member is actively promoting the journal’s Scopus inclusion news
Exploration of Neuroprotective Therapy accepted for Scopus
ENT promoted in the International Congress on Neurodegenerative Diseases ICND2024